Femarelle® and bone mineral density - Scientific substantiation of a health claim related to “Femarelle®” and “induces bone formation and increases bone mineral density reducing the risk for osteoporosis and other bone disorders” pursuant to Article 14 of the Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

Tabs

Article
Bone formation, bone mineral density, osteoporosis, post-menopausal women
First published in the EFSA Journal: 
21 August 2008
Adopted: 
4 August 2008
Type: 
Opinion of the Scientific Committee/Scientific Panel
Read it on the Wiley Online Library: Article | PDF
Abstract: 

No abstract available

Panel members at the time of adoption: 
Jean-Louis Bresson, Albert Flynn, Marina Heinonen, Karin Hulshof, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Andreu Palou, Hildegard Przyrembel, Seppo Salminen, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Henk van den Berg, Hendrik van Loveren and Hans Verhagen.
Panel on Dietetic Products, Nutrition and Allergies
doi: 
10.2903/j.efsa.2008.785
Question Number: 
EFSA-Q-2008-078